Loading…
Takeda Pharmaceutical Company Limited is projected to rise to $21.60 by 2027, a +34% move from its current price of $16.15. TAK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $15.98 | $16.15 | $16.32 | +0.01% |
| May 30 | $15.92 | $16.15 | $16.39 | +0.03% |
| May 31 | $15.87 | $16.16 | $16.45 | +0.04% |
| Jun 1 | $15.82 | $16.16 | $16.50 | +0.05% |
| Jun 2 | $15.79 | $16.16 | $16.54 | +0.06% |
| Jun 3 | $15.75 | $16.16 | $16.58 | +0.08% |
| Jun 4 | $15.72 | $16.16 | $16.62 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.72 | $16.16 | $16.62 | +0.09% |
| Week 2 | $15.56 | $16.18 | $16.82 | +0.18% |
| Week 3 | $15.44 | $16.19 | $16.99 | +0.27% |
| Week 4 | $15.34 | $16.21 | $17.13 | +0.36% |
| Week 5 | $15.25 | $16.22 | $17.26 | +0.45% |
| Week 6 | $15.17 | $16.24 | $17.37 | +0.54% |
| Week 7 | $15.11 | $16.25 | $17.48 | +0.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Takeda Pharmaceutical Company Limited is a healthcare company that engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The portfolio includes brands such as Entyvio, Dexilant, Takecab/Vocinti, EOHILIA, Alofisel, and others across multiple therapeutic areas.
The company was founded in 1781 and is headquartered in Tokyo, Japan.
Takeda is currently priced at $16.21 per share with a market capitalization of $51.2B, ranking 311 by market cap. The stock trades in a mid-$teens range and sits within a broader market context that includes a 30-day technical picture and a multi-year forecast.
Near term, the model projects a 30-day path centered around a 2026 average of $16.21 with a high forecast of $22.09, and a neutral sentiment for that near term window. In the big picture, the price outlook is bullish for several years ahead, with the average forecast rising substantially from 2026 through 2050.
Over the long horizon, the forecast shows a clear upward trajectory: the 2030 average is $31.26 and the 2050 average is $152.18, with substantial upside potential in between. Max forecast values reach $42.71 (2030), $110.55 (2040), and $249.02 (2050), accompanied by robust ROI figures across the period.
A major floor 9.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.7% away) — a key level to hold.
The nearest ceiling, 10.5% above — a clean break opens room to run.
A major ceiling 16.4% above — clearing it would confirm fresh momentum.
Key TAK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TAK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $16.29 | Sell | $16.23 | Sell |
| MA 10 | $16.45 | Sell | $16.36 | Sell |
| MA 20 | $16.49 | Sell | $16.55 | Sell |
| MA 50 | $17.29 | Sell | $16.96 | Sell |
| MA 100 | $17.36 | Sell | $16.87 | Sell |
| MA 200 | $15.96 | Buy | $16.28 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.16 | Neutral |
| Stoch RSI (14) | 56.02 | Neutral |
| CCI (20) | -139.47 | Sell |
| Williams %R (14) | -65.43 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -1.88 | Sell |
| Bollinger %B (20,2) | 0.09 | Neutral |
| Stochastic %K (14) | 34.57 | Neutral |
| TRIX (15) | -0.24 | Sell |
| Awesome (5,34) | -0.56 | Sell |
| Ultimate (7,14,28) | 32.46 | Neutral |
| Momentum (10) | -0.27 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 16.02 | Buy |
| ADX (14) | 25.03 | Sell |
| ATR (14) | 0.16 | Info |
30-day technical picture shows a bullish tilt in sentiment with RSI(14) at 40. The near-term moving averages place the price around the $17.37 level for the 50-day SMA and $15.95 for the 200-day SMA. Support sits at $16.20 and resistance at $17.85, with the 30-day price range spanning $16.20 to $17.24 and a prior range of $15.23 to $17.24.
These near-term indicators suggest a relatively tight trading range just above the near-term support while offering upside above the $17.85 resistance level if momentum strengthens.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.62 | $16.15 | $21.84 | 0% | Neutral | |
| $17.64 | $21.60 | $27.67 | +34% | Bullish | |
| $20.22 | $25.20 | $33.14 | +56% | Bullish | |
| $21.25 | $26.88 | $36.08 | +66% | Bullish | |
| $23.36 | $29.95 | $40.91 | +85% | Bullish | |
| $24.41 | $31.67 | $43.93 | +96% | Bullish | |
| $25.16 | $33.01 | $46.43 | +104% | Bullish | |
| $28.84 | $38.24 | $54.48 | +137% | Bullish | |
| $33.61 | $45.00 | $64.87 | +179% | Bullish | |
| $37.03 | $50.05 | $72.95 | +210% | Bullish | |
| $47.15 | $66.46 | $101.48 | +312% | Bullish | |
| $91.95 | $138.97 | $227.39 | +761% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $15.62 | $16.15 | $18.83 | +0.00% |
| June 2026 | $13.67 | $15.95 | $18.97 | -1.23% |
| July 2026 | $13.93 | $16.34 | $19.61 | +2.44% |
| August 2026 | $13.99 | $16.49 | $19.94 | +0.91% |
| September 2026 | $13.86 | $16.39 | $19.94 | -0.58% |
| October 2026 | $14.22 | $16.88 | $20.64 | +2.94% |
| November 2026 | $14.75 | $17.57 | $21.58 | +4.09% |
| December 2026 | $14.82 | $17.69 | $21.84 | +0.73% |
Click any year to see its month-by-month TAK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The TAK price prediction for 2026 points to an average of $16.15 (low $15.62, high $21.84) — a potential gain of 0% on today's $16.15. A consolidation phase looks the most probable path here.
In 2027, TAK is projected to trade between $17.64 and $27.67, averaging $21.60 — a potential gain of +34% from today's $16.15. That is up +34% on the projected 2026 average. Momentum favours further upside here.
Takeda Pharmaceutical Company Limited's 2028 outlook centres on $25.20, within a $20.22 to $33.14 range. That is up +17% on the projected 2027 average. That marks a +56% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, TAK could reach as high as $36.08, with a base case around $26.88 and support toward $21.25 — roughly +66% from $16.15. Momentum favours further upside here.
Expect TAK to range from $23.36 to $40.91 through 2030. The $29.95 average target implies a +85% move from current prices. That is up +11% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The TAK price prediction for 2031 points to an average of $31.67 (low $24.41, high $43.93) — a potential gain of +96% on today's $16.15. Momentum favours further upside here.
In 2032, TAK is projected to trade between $25.16 and $46.43, averaging $33.01 — a potential gain of +104% from today's $16.15. That is up +4% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Takeda Pharmaceutical Company Limited's 2033 outlook centres on $38.24, within a $28.84 to $54.48 range. That is up +16% on the projected 2032 average. That marks a +137% change versus current levels. Momentum favours further upside here.
By 2034, TAK could reach as high as $64.87, with a base case around $45.00 and support toward $33.61 — roughly +179% from $16.15. Buyers look set to stay in control over this stretch.
Expect TAK to range from $37.03 to $72.95 through 2035. The $50.05 average target implies a +210% move from current prices. That is up +11% on the projected 2034 average. Momentum favours further upside here.
The TAK price prediction for 2040 points to an average of $66.46 (low $47.15, high $101.48) — a potential gain of +312% on today's $16.15. Buyers look set to stay in control over this stretch.
In 2050, TAK is projected to trade between $91.95 and $227.39, averaging $138.97 — a potential gain of +761% from today's $16.15. That is up +109% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in TAK today (≈ 61.919505 TAK) could be worth
$8,604.96
+$7,604.96 (+760%) by 2050 · US Dollar
Based on the average projected TAK price of $138.97 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TAKwould be worth at today's price.
$1,000 invested in TAK on May 27, 2025 (≈ 68.166325 TAK) would be worth
$1,100.89
+$100.89 (+10.1%) today · 1.10× · US Dollar
Based on a TAK entry price of $14.67 vs. today's $16.15.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $16.68 | $968.23 | -3.2% |
| 1 month ago | $16.36 | $987.16 | -1.3% |
| 3 months ago | $18.53 | $871.56 | -12.8% |
| 6 months ago | $14.42 | $1,119.97 | +12.0% |
| 1 year ago | $14.67 | $1,100.89 | +10.1% |
| All time (5.0y) ago | $16.67 | $968.81 | -3.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TAK forecast.
Our base-case forecast reaches $32.00 around 2032.
Implied market cap at $32.00: $101.11B
The multi-year forecast shows a bullish trajectory, with 2030 posting an average of $31.26 and a max of $42.71 (min $24.38) and a ROI of 92.9%. This reflects a substantial rise from the 2026 base and implies meaningful appreciation as the years progress.
By 2040, the forecast calls for an average of $72.39 and a max of $110.55 (min $51.35), with a ROI of 346.7%, underscoring strong long-term upside potential.
In 2050, the average is projected at $152.18 with a max of $249.02 (min $100.67), delivering a ROI of 839.1% and a bullish long-term stance.
These figures illustrate an extended bullish scenario with rising averages and outsized ROIs, though it is important to treat them as estimates rather than guarantees and acknowledge the inherent uncertainty in long-term price forecasting.
Tap a question to reveal the answer.
The forecast shows an average price of $31.26 in 2030, with a minimum of $24.38 and a maximum of $42.71. The predicted ROI for 2030 is 92.9% and the sentiment is BULLISH.
Long-term forecasts show a bullish trajectory, with 2030, 2040, and 2050 averages of $31.26, $72.39, and $152.18 respectively, and ROIs of 92.9%, 346.7%, and 839.1%. The near-term outlook for 2026 is neutral, but the longer horizon indicates meaningful upside potential, acknowledging the estimates are not guarantees.
Yes. The 2040 forecast maximum is $110.55, which exceeds $100, according to the provided projections.
The current price is $16.21 and the market cap is $51.2B. The stock is ranked 311 by market cap.
RSI(14) is 40 with a bullish overall sentiment. The 50-day SMA is $17.37 and the 200-day SMA is $15.95. Support is at $16.20 and resistance at $17.85. The 30-day price range is $15.23 to $17.24.
Takeda Pharmaceutical Company Limited Community Discussion
0Share your Takeda Pharmaceutical Company Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.